• Tranexamic Acid Injection 500mg/5ml, GMP Drug
  • Tranexamic Acid Injection 500mg/5ml, GMP Drug
  • Tranexamic Acid Injection 500mg/5ml, GMP Drug
  • Tranexamic Acid Injection 500mg/5ml, GMP Drug
  • Tranexamic Acid Injection 500mg/5ml, GMP Drug
  • Tranexamic Acid Injection 500mg/5ml, GMP Drug

Tranexamic Acid Injection 500mg/5ml, GMP Drug

Application: Anti-Infective
Usage Mode: Injection
Suitable for: Children, Adult
State: Liquid
Shape: Water Injection
Type: Western Finished Medicine
Samples:
US$ 0/box 1 box(Min.Order)
| Request Sample
Customization:

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
AMC14072
Pharmaceutical Technology
Chemical Synthesis
Shelf-Life
3 Years
Specification
10′s/box
Trademark
Anhui Medipharm; Shinepharm; OEM
Origin
China
HS Code
3004909099

Product Description

Product Description

Characteristics:
This product is a clear colorless liquid.
 
Indications:

This product is mainly used for the treatment of acute or chronic, localized or systemic primary fibrinolysis caused by various bleeding, this product can also be used:
1. Trauma or surgical bleeding of plasminogen activator in prostate, urethra, lung, brain, uterus, adrenal gland, thyroid gland and other organs;
2. Used as an antagonist of tissue plasminogen activator (T-PA) streptokinase and urokinase;
3. Induced abortion, early placental abruption, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding, and pathologic intrauterine local increased fibrinolytic menorrhagia;
4. Used to prevent or reduce bleeding after tooth extraction or oral surgery for hemophiliacs lacking factor
5. Mild bleeding caused by central nervous diseases, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage, hemostasis using this product is superior to other anti-fibrinolytic drugs, but the risk of complicated cerebral edema or cerebral infarction must be paid attention to; For severe patients with surgical indications, this product can only be used as an adjuvant;
6. For the treatment of hereditary angoneeurotic edema, can reduce the frequency and severity of its attack;
7. Hemophilia patients with active bleeding can be combined with this drug.
Usage and Dosage:

Pulse injection or infusion, 0.25 ~ 0.5g, 0.75 ~ 2g a day. In order to prevent bleeding before and after surgery, the dose mentioned above can be referred to. In order to treat bleeding caused by primary fibrinolysis, the dose can be increased as appropriate.
Interactions:
1. Incompatibility with penicillin, urokinase and other suppositories or blood infusion;
2. The combination of oral contraceptives, estrogen or prothrombin complex with this product may increase the risk of thrombosis.
Storage:
Shading, airtight storage (10 ~ 30ºC).
 
Production:
Tranexamic Acid Injection 500mg/5ml, GMP Drug

 

Inspection:
Tranexamic Acid Injection 500mg/5ml, GMP Drug
Loading:
Tranexamic Acid Injection 500mg/5ml, GMP Drug
Certificates:
Tranexamic Acid Injection 500mg/5ml, GMP Drug

  

 


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License